Prophylaxis of cytomegalovirus disease in high-risk patients.

被引：2
|
作者：
Scholz, M
Cinatl, J
Doerr, W
机构：
[1] Johann Wolfgang Goethe-Universität,Institut für Medizinische Virologie
来源：
INFECTION | 1997年 / 25卷 / 05期
关键词：
D O I：
10.1007/BF01720395
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
CMV disease is an important peristent factor for enhanced morbidity and mortality in immunocompromised patients. In high-risk patients the prevention of primary infection or reactivation of latent infection is endeavoured by means of various antiviral strategies. However, the prevention of CMV disease by immunomodulators appears to be a hopeful additional tool for the treatment of immunocompromised patients and ought to be further investigated.
引用
收藏
页码：269 / 273
页数：5
相关论文
共 50 条
  • [41] Prophylaxis of venous thromboembolic disease in high-risk orthopedic surgery
    Meza Reyes, Gilberto Eduardo
    Esquivel Gomez, Ricardo
    del Campo Sanchez, Antonio Martinez
    Espinosa-Larranaga, Francisco
    Enrique Martinez Guzman, Miguel Angel
    Torres Gonzalez, Ruben
    de la Fuente Zuno, Juan Carlos
    Mendez Huerta, Juan Vicente
    Villalobos Garduno, Enrique
    Cymet Ramirez, Jose
    Ibarra Hirales, Efren
    Diaz Borjon, Efrain
    Aguilera Zepeda, Jose Manuel
    Valles Figueroa, Juan Francisco
    Majluf-Cruz, Abraham
    GACETA MEDICA DE MEXICO, 2012, 148 (02): : 144 - 152
  • [42] High-Risk Oncogenic Human Cytomegalovirus
    Herbein, Georges
    VIRUSES-BASEL, 2022, 14 (11):
  • [43] Identifying and Prophylaxis of High-risk GI Bleeders in Cardiac Patients
    Vu, Loan
    Troutman, Monte
    Otulana, Ola
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S469 - S469
  • [44] Quetiapine for delirium prophylaxis in high-risk critically ill patients
    Abraham, Matthew P.
    Hinds, Melisande
    Tayidi, Isson
    Jeffcoach, David R.
    Corder, James M.
    Hamilton, Leslie A.
    Lawson, Christie M.
    Bollig, Reagan W.
    Heidel, R. Eric
    Daley, Brian J.
    Taylor, Jessica E.
    McMillen, James C.
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2021, 19 (02): : 65 - 71
  • [45] Venous Thromboembolism Prophylaxis in High-Risk Pediatric Trauma Patients
    Witte, Amanda B.
    Van Arendonk, Kyle
    Bergner, Carisa
    Bantchev, Martin
    Falcone, Richard A.
    Moody, Suzanne
    Hartman, Heather A.
    Evans, Emily
    Thakkar, Rajan
    Patterson, Kelli N.
    Minneci, Peter C.
    Mak, Grace Z.
    Slidell, Mark B.
    Johnson, MacKenton
    Landman, Matthew P.
    Markel, Troy A.
    Leys, Charles M.
    Stafford, Linda Cherney
    Draper, Jessica
    Foley, David S.
    Downard, Cynthia
    Skaggs, Tracy M.
    Lal, Dave R.
    Gourlay, David
    Ehrlich, Peter F.
    JAMA SURGERY, 2024, 159 (10) : 1149 - 1156
  • [46] Is there still a place for itraconazole prophylaxis in high-risk hematology patients?
    S. J. van Hal
    S. R. Larsen
    R. C. Chan
    Annals of Hematology, 2014, 93 : 1617 - 1618
  • [47] Isoniazid prophylaxis for high-risk patients with anergy and HIV infection
    Dore, GJ
    Law, MG
    Kaldor, KM
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (23): : 1697 - 1697
  • [48] Venous Thromboembolism Prophylaxis in High-Risk Pediatric Oncology Patients
    McCarty, Kyra L.
    Staggs, Vincent S.
    Bolen, Erin E.
    Massey, Justin K.
    Amos, Lauren E.
    BLOOD, 2022, 140 : 5688 - 5689
  • [49] EFFICACY OF ZOSTER IMMUNOGLOBULIN IN PROPHYLAXIS OF VARICELLA IN HIGH-RISK PATIENTS
    WINSNES, R
    ACTA PAEDIATRICA SCANDINAVICA, 1978, 67 (01): : 77 - 82
  • [50] Nystatin prophylaxis: efficient in high-risk nonimmunocompromised ICU patients?
    Philippe Vignon
    Sandrine Normand
    Marie-Laure Dardé
    Bruno François
    Intensive Care Medicine, 2006, 32 : 935 - 935
12345